Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

What happened: Parse Biosciences and Nomic Bio announced a partnership to generate Cascade, a 100 million cell multimodal perturbation dataset for understanding the human immune response. Key numbers: 100 million single-cell RNA-seq profiles; more than 11,000 proteomic secretome profiles; over 150,000 perturbation conditions; Why it matters: Cascade has foundational partner commitments from GSK, Pfizer, Sanofi, Graph Therapeutics, and Turbine. Parse's CTO said biological AI modeling has hit a data bottleneck, and the companies expect the dataset to improve partners' predictive AI models. Market: -4.3% today ($48.74), -0.1% YTD, 1.4x vol — as of 22:46 UTC

Parse Biosciences and Nomic Bio announced a partnership to generate Cascade, a 100 million cell multimodal perturbation dataset for understanding the human immune response.

Cascade has foundational partner commitments from GSK, Pfizer, Sanofi, Graph Therapeutics, and Turbine. Parse's CTO said biological AI modeling has hit a data bottleneck, and the companies expect the dataset to improve partners' predictive AI models. Market: -4.3% today ($48.74), -0.1% YTD, 1.4x vol — as of 22:46 UTC